Canopy Growth (CGC) EPS (Basic) Growth (1y) (2020 - 2025)
Canopy Growth (CGC) EPS (Basic) Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Canopy Growth | 442.95 Mn | 195.94 Mn | 16.08 Mn | 85.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -148.01% |
| Sep 30, 2024 | 101.49% |
| Jun 30, 2024 | 104.48% |
| Mar 31, 2024 | 102.44% |
| Dec 31, 2023 | 120.99% |
| Sep 30, 2023 | -3.47% |
| Jun 30, 2023 | 98.97% |
| Mar 31, 2023 | 90.88% |
| Dec 31, 2022 | 75.55% |
| Sep 30, 2022 | -438.92% |
| Jun 30, 2022 | -598.46% |
| Mar 31, 2022 | -342.70% |
| Dec 31, 2021 | 86.36% |
| Sep 30, 2021 | 83.08% |
| Jun 30, 2021 | 424.68% |
| Mar 31, 2021 | 92.49% |
| Dec 31, 2020 | -615.85% |
| Sep 30, 2020 | -136.84% |
| Jun 30, 2020 | 39.17% |
| Mar 31, 2020 | -1,261.57% |